Motesanib Terminated Phase 2 Trials for Breast Neoplasms / Breast Tumor / Locally Recurrent and Metastatic Breast Cancer / Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00356681A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer